Sponsor:
Applied Biologics, LLC
Code:
NCT07852338
Conditions
Diabetic Foot Ulcer
Amniotic Membrane Placental Allograft
Biologic
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Standard of Care
BIOxHEAL (human amniotic membrane allograft)
Brief summary:
Conditions
Diabetic Foot Ulcer
Amniotic Membrane Placental Allograft
Biologic
Study ID
NCT07852338
Start date
Oct 8, 2026
Status verified date
Oct, 2026
Completion date
Sep, 2027
Anticipated
Primary completion date
Sep, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
253 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Sentinel Cohort: BIOxHEAL + SOC
active comparator: Randomized: SOC Alone
experimental: Randomized: BIOxHEAL + SOC
Interventions
Standard of Care
BIOxHEAL (human amniotic membrane allograft)
Primary outcome measure
Central contacts
Locations
NOMS Ankle and Foot Care Center
Recruiting
Boardman, Ohio, United States, 44512
Contacts
Sponsor
Applied Biologics, LLC
Last update posted
Oct 16, 2026
Last verified
Oct, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-16. This information was provided to ClinicalTrials.gov by Applied Biologics, LLC on 2026-10-16. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.